Questioning the status of aberrant speech patterns as psychiatric symptoms

SummarySpeech disturbances manifest in various psychiatric conditions and demonstrate temporal variability in relation to acute and stable symptom periods. They can be externally assessed, which facilitates their potential use as an objective marker of illness stage. Continued research will have positive implications for diagnostics and long-term management in clinical settings.

Download Full-text

CM-Pf deep brain stimulation and the long term management of motor and psychiatric symptoms in a case of Tourette syndrome

Journal of Clinical Neuroscience ◽

10.1016/j.jocn.2018.12.029 ◽

2019 ◽

Vol 62 ◽

pp. 269-272 ◽

Cited By ~ 3

Author(s):

Massimo Marano ◽

Simone Migliore ◽

Ferdinando Squitieri ◽

Angelo Insola ◽

Eugenio Scarnati ◽

...

Keyword(s):

Deep Brain Stimulation ◽

Tourette Syndrome ◽

Brain Stimulation ◽

Psychiatric Symptoms ◽

Term Management ◽

Deep Brain

Download Full-text

The Identification and Management of Malingering in Clinical Settings

10.2310/psych.13073 ◽

2020 ◽

Author(s):

Lauren Dent ◽

Scott Simpson

Keyword(s):

Psychological Symptoms ◽

Neuropsychological Testing ◽

Clinical Settings ◽

Factitious Disorder ◽

Financial Gain ◽

Adaptive Choice ◽

Psychiatric Conditions ◽

Long Term Prognosis ◽

External Incentives

Malingering is the “intentional production of false or grossly exaggerated physical or psychological symptoms, motivated by external incentives.” Malingering is difficult to identify and a challenge for physicians to manage. There are innumerable incentives for malingering, including financial gain, housing, and controlled substances. Although there is no definitive way to identify malingering, clues that suggest malingering include inconsistencies in history and exam, discrepancies among collateral informants, and the results of neuropsychological testing. By recognizing how malingering may be a rational, adaptive choice for patients to address their needs, psychiatrists can preserve the doctor-patient relationship and build an alliance to achieve the patient’s goals in a more productive manner. Pitfalls for clinicians treating malingering patients include burnout, aversive countertransference reactions, and inadequate treatment of comorbid medical or psychiatric conditions. Psychiatrists must also be attentive to appropriate documentation and personal safety. The long-term prognosis of malingering patients is not well understood. This review contains 5 figures, 7 tables, and 95 references. Key words: malingering, external incentive, forensic psychiatry, factitious disorder, antisocial personality disorder, countertransference, confrontation

Download Full-text

Lessons from the long-term management plan for northern hake: could the economic assessment have accepted it?

ICES Journal of Marine Science ◽

10.1093/icesjms/fsr105 ◽

2011 ◽

Vol 68 (9) ◽

pp. 1937-1941 ◽

Cited By ~ 14

Author(s):

José-María Da Rocha ◽

María-José Gutiérrez

Keyword(s):

Net Present Value ◽

Economic Assessment ◽

Management Plan ◽

Economic Consequences ◽

Economic Indicators ◽

Biological Assessment ◽

The Status ◽

Age Structured ◽

Term Management

Abstract Da Rocha, J-M., and Gutiérrez, M-J. 2011. Lessons from the long-term management plan for northern hake: could the economic assessment have accepted it? – ICES Journal of Marine Science, 68: 1937–1941. An economic working group was convened by the EU's Scientific, Technical and Economic Committee for Fisheries (STECF) in 2007 to evaluate the potential economic consequences of the long-term management plan for the northern hake (Merluccius merluccius) stock. An analysis of all the scenarios proposed by the biological assessment using the Economic Interpretation of ACFM Advice (EIAA) model showed that F at the status quo level was the best policy for both yield and profits, in terms of net present values. This result is counter-intuitive because it seems to suggest that effort costs do not influence economic indicators, whereas it is widely accepted that including costs negatively affects economic indicators. A dynamic age-structured model is applied to northern hake and shows that the optimal fishing mortality that maximizes the net present value of profits is <Fmax. The reason why the EIAA analysis was biased towards scenarios with F > Fmax is also shown.

Download Full-text

On-demand therapy with pantoprazole 20 mg O.D. (PANTO) for the long-term management of GERD patients previously healed from heartburn

Gastroenterology ◽

10.1016/s0016-5085(01)82173-9 ◽

2001 ◽

Vol 120 (5) ◽

pp. A438-A438

Author(s):

T SCHOLTEN ◽

G GATZ ◽

P SANDER

Keyword(s):

On Demand ◽

Term Management

Download Full-text

Long-term Management of Neurogenic Bladder: An Eclectic Approach

Physical Medicine and Rehabilitation Clinics of North America ◽

10.1016/s1047-9651(18)30585-0 ◽

1993 ◽

Vol 4 (2) ◽

pp. 329-342 ◽

Cited By ~ 2

Author(s):

L. Keith Lloyd

Keyword(s):

Neurogenic Bladder ◽

Eclectic Approach ◽

Term Management

Download Full-text

Childhood Asthma's Self-Efficacy Scale--Parental Long-Term Management

PsycTESTS Dataset ◽

10.1037/t71715-000 ◽

2012 ◽

Author(s):

Misa Iio ◽

Kosuke Maeba ◽

Takashi Shimazaki ◽

Yukihiro Ohya ◽

Koji Takenaka

Keyword(s):

Self Efficacy ◽

Term Management

Download Full-text

Long-Term Management of Contaminated Sites

10.1016/s0196-1152(2006)13 ◽

2006 ◽

Cited By ~ 2

Keyword(s):

Contaminated Sites ◽

Term Management

Download Full-text

Long-Term Management of Chronic Invasive Skull Base Aspergilloma with Oral Voriconazole

Journal of Neurological Surgery Part B Skull Base ◽

10.1055/s-0035-1546676 ◽

2015 ◽

Vol 76 (S 01) ◽

Author(s):

Rebecca Harvey ◽

Erin Mckean

Keyword(s):

Skull Base ◽

Term Management ◽

Chronic Invasive

Download Full-text

Treatment and secondary prevention of venous thromboembolism in cancer patients

Onkologische Welt ◽

10.1055/s-0038-1630173 ◽

2012 ◽

Vol 03 (03) ◽

pp. 121-125

Author(s):

I. Pabinger ◽

C. Ay

Keyword(s):

Clinical Trials ◽

Venous Thromboembolism ◽

Cancer Patients ◽

Oral Anticoagulants ◽

Factor Xa ◽

New Oral Anticoagulants ◽

Phase Iii ◽

Patients With Cancer ◽

Potential Use

SummaryCancer is a major and independent risk factor of venous thromboembolism (VTE). In clinical practice, a high number of VTE events occurs in patients with cancer, and treatment of cancerassociated VTE differs in several aspects from treatment of VTE in the general population. However, treatment in cancer patients remains a major challenge, as the risk of recurrence of VTE as well as the risk of major bleeding during anticoagulation is substantially higher in patients with cancer than in those without cancer. In several clinical trials, different anticoagulants and regimens have been investigated for treatment of acute VTE and secondary prophylaxis in cancer patients to prevent recurrence. Based on the results of these trials, anticoagulant therapy with low-molecular-weight heparins (LMWH) has become the treatment of choice in cancer patients with acute VTE in the initial period and for extended and long-term anticoagulation for 3-6 months. New oral anticoagulants directly inhibiting thrombin or factor Xa, have been developed in the past decade and studied in large phase III clinical trials. Results from currently completed trials are promising and indicate their potential use for treatment of VTE. However, the role of the new oral thrombin and factor Xa inhibitors for VTE treatment in cancer patients still has to be clarified in further studies specifically focusing on cancer-associated VTE. This brief review will summarize the current strategies of initial and long-term VTE treatment in patients with cancer and discuss the potential use of the new oral anticoagulants.

Download Full-text